izpis_h1_title_alt

In vitro characterization of the human skeletal stem cell-like properties of primary bone-derived mesenchymal stem /stromal cells in patients with late and early hip osteoarthritis
ID Jasenc, Lara (Author), ID Stražar, Klemen (Author), ID Trebše, Rihard (Author), ID Mihelič, Anže (Author), ID Mihalič, Rene (Author), ID Jeras, Matjaž (Author), ID Zupan, Janja (Author)

.pdfPDF - Presentation file, Download (3,56 MB)
MD5: 37490B7D70B20D6149AA2F3B5D526C17
URLURL - Source URL, Visit https://www.mdpi.com/2075-1729/12/6/899 This link opens in a new window

Abstract
Human skeletal stem cells (hSSCs) were recently identified as podoplanin (PDPN)/CD73/CD164-positive and CD146-negative cells that decline with age, and play a role in the pathogenesis of osteoarthritis (OA). The aim of this study was to identify the hSSC-like properties of bone-derived mesenchymal stem/stromal cells (MSCs) of patients with late and early OA. Methods: First, we performed gene expression profiling for the hSSC markers in 32 patients with late and early OA, and donors without OA. Having identified the low expression of hSSC markers in late OA patients, we further performed trilineage differentiation and immunophenotyping for hSSC makers in the selected subsets from each donor group. Results: Our results show no differences in osteogenesis, chondrogenesis, and adipogenesis between the MSCs from the three groups. However, the immunophenotyping shows lower CD164 in MSCs from early OA patients in comparison with late and no OA subjects (p = 0.002 and p = 0.017). Conclusions: Our study shows that the in vitro hSSC-like properties of bone-derived MSCs are similar in patients with early and late OA, and in donors without OA. However, the lower percentage of CD164-positive MSCs in early OA patients indicates the potential of CD164 as a marker of the onset of OA.

Language:English
Keywords:human skeletal stem cells (hSSCs), late osteoarthritis (OA), early OA, bone-derived, mesenchymal stem/stromal cells (MSCs), podoplanin (PDPN), CD73, CD164, CD146, trilineage, differentiation, immunophenotyping
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
MF - Faculty of Medicine
Publication version:Version of Record
Publication date:01.01.2022
Year:2022
Number of pages:Str. 1-15
Numbering:Vol. 12, iss. 6, art. 899
PID:20.500.12556/RUL-140238 This link opens in a new window
UDC:617.3
ISSN on article:2075-1729
DOI:10.3390/life12060899 This link opens in a new window
COBISS.SI-ID:112107267 This link opens in a new window
Publication date in RUL:13.09.2022
Views:361
Downloads:80
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Life
Shortened title:Life
Publisher:MDPI
ISSN:2075-1729
COBISS.SI-ID:519982617 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:13.09.2022

Secondary language

Language:Slovenian
Keywords:artroza, kostne matične celice, kolk, človeške skeletne izvorne celice (hSSC), pozni osteoartritis (OA), zgodnji OA, mezenhimske matične/stromalne celice (MSC) iz kosti, podoplanin (PDPN), CD73, CD164, CD146, trirodnost, diferenciacija, imunofenotipizacija

Projects

Funder:ARRS - Slovenian Research Agency
Project number:J3-1749-2019
Name:Mezenhimske matične celice-nosilci endogene regenerativne sposobnosti tkiv v boju proti staranju mišično-skeletnega sistema

Funder:ARRS - Slovenian Research Agency
Project number:P1-0420-2022
Name:Napredna imunološka zdravila in celični pristopi v farmaciji

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back